União Europeia -
norueguês -
EMA (European Medicines Agency)
xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibakterielle midler for systemisk bruk, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.
Noruega -
norueguês -
Statens legemiddelverk
melatonin agb 5 mg
agb-pharma ab - melatonin - tablett - 5 mg
Noruega -
norueguês -
Statens legemiddelverk
melatonin agb 1 mg
agb-pharma ab - melatonin - tablett - 1 mg
Noruega -
norueguês -
Statens legemiddelverk
melatonin agb 2 mg
agb-pharma ab - melatonin - tablett - 2 mg
Noruega -
norueguês -
Statens legemiddelverk
melatonin agb 3 mg
agb-pharma ab - melatonin - tablett - 3 mg
Noruega -
norueguês -
Statens legemiddelverk
melatonin agb 4 mg
agb-pharma ab - melatonin - tablett - 4 mg
Noruega -
norueguês -
Statens legemiddelverk
melatonin orifarm 2 mg
orifarm generics a/s - melatonin - tablett, filmdrasjert - 2 mg
Noruega -
norueguês -
Statens legemiddelverk
melatonin unimedic pharma 1 mg/ ml
unimedic pharma ab - melatonin - mikstur, oppløsning - 1 mg/ ml
Noruega -
norueguês -
Statens legemiddelverk
melatonin teva 2 mg
teva b.v. - melatonin - depottablett - 2 mg
União Europeia -
norueguês -
EMA (European Medicines Agency)
kapruvia
vifor fresenius medical care renal pharma france - difelikefalin - pruritus - alle andre terapeutiske produkter - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.